Following an independent salary analysis, this landmark certification sets a benchmark for data-driven pay equity and ...
Highly Experienced US-Based Public Markets Leader Strengthens Team as Company Drives Late Stage Development of LEVI-04 for Osteoarthritis ...
Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...
Island Pharmaceutical’s experimental drug will be used to treat patients in Uganda, as the African nation grapples with the ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that it will present new data from its Alzheimer’s disease portfolio at the Alzheimer’s Association International ...
The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...
Brandon Capital will receive more than $300 million from the sale of Myricx, which is developing cancer-killing “biological ...
Investor's Business Daily on MSN
Vertex Pharma makes a $10 billion deal; Crinetics stock doubles
Crinetics stock nearly doubled late Monday after Vertex Pharmaceuticals pledged $10 billion to buy the endocrinology-focused biotech company.
Investor's Business Daily on MSN
Why this biotech, up 12% since its breakout, yo-yoed on a key FDA development
Pharvaris stock jumped early Monday, but closed down, after the FDA agreed to review the company's treatment for a serious ...
A series of biotech acquisitions transpired in under 9 months — totaling more than $3.5 billion. The drugs behind them target ...
Novartis will pay $1.1bn upfront and up to $400m in milestones for Myricx Bio, a UK firm developing a novel payload for antibody-drug conjugates.
Strengthens the Novartis oncology pipeline with two lead ADC assets and a broader payload platform with potential impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results